Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic

Cytotherapy

Volumn 12, Issue 4, 2010, Pages 563-565

  Wang, Hengxiang ^a   Wang, Zhidong ^a   Xue, Mei ^a   Liu, Jing ^a   Yan, Hongmin ^a   Guo, Zikuan ^b  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Hematopoietic stem cell transplantation; HLA haplo identical; Mesenchymal stromal cells; Severe aplastic anemia

Indexed keywords

BASILIXIMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FLUDARABINE; HLA DR ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP TYPING; BONE MARROW BIOPSY; CASE REPORT; CHILD; DNA FINGERPRINTING; DRUG DOSE REDUCTION; ENGRAFTMENT; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT RECIPIENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; HUMAN CELL CULTURE; HYPOPLASIA; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUTROPHIL COUNT; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT DURATION;

EID: 77954432661     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653241003695059     Document Type: Article

References (10)

1. Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haplo- identical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2006;107: 3065-3073
2. Wang HX, Yan HM, Duan LN, Wang ZD, Zhu L, Xue M, et al. Haplo-identical hematopoietic stem cell transplantation in children hematologic malignancies with G-CSF mobilized marrow grafts without T cell depletion: a single center report of 45 cases. Pediatr Hematol Oncol. 2009;26:119-128
3. Woodard P, Cunningham JM, Benaim E, Chen X, Hale G, Horwitz E, et al. Effective donor lymphohematopoietic reconstitution after haplo-identical CD34-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia. Bone Marrow Transplant. 2004;33:411-418
4. Lacerda JF, Martins C, Carmo JA, Lourenç o F, Juncal C, Ismail S, et al. Haplo-identical stem cell transplantation with purifi ed CD34- cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia. Biol Blood Marrow Transplant. 2005;11:399-400.
5. Tsutsumi Y, Tanaka J, Miura T, Saitoh S, Yamada M, Yamato H, et al. Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haplo-identical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism. Bone Marrow Transplant. 2004;34:267-269
6. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009; 11:503-515
7. Fang B, Song Y, Li N, Li J, Zhao RC. Cotransplantation of haplo-identical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemia. Acta Haematol. 2008;119:162-165
8. Fang B, Li N, Song Y, Li J, Zhao RC, Ma Y. Cotransplantation of haplo-identical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia. Pediatr Transplant. 2009;13:499-502.
9. LaCorcia G, Swistak M, Lawendowski C, Duan S, Weeden T, Nahill S, et al. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion. Transplantation. 2009;87:966-974
10. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haplo-identical hematopoietic stem-cell transplantation. Blood. 2007;110: 2764-2767